Chronic Kidney Disease-associated Pruritus
Conditions
Keywords
CKD, CKD-AP, CKD associated pruritus
Brief summary
Vifor International Inc. is seeking real-world evidence (RWE) to better understand the epidemiology, patient characteristics, and management of CKD-aP in the real-world clinical setting.
Detailed description
This is a non-interventional, cross-sectional, multicentre, and multinational (European) study. The non-interventional study (NIS) design allows the observation of patients in large haemodialysis (HD) centres reflecting routine clinical practice. All decisions on therapeutic or diagnostic procedures, treatments, management of the disease, or resource utilisation will be at the full discretion of the treating physician without interference by the sponsor or study protocol. All treatment decisions will follow the real-life treatment behaviour. The CENSUS-EU represents a cross-sectional study design of a representative selection of patients undergoing HD at 113 large dialysis centres across 7 countries in Europe. Prot. v.2.0, 9 May 2023
Interventions
None listed
Sponsors
Vifor (International) Inc.
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Male or female adult patients with CKD (≥18 years) receiving HD for at least 3 months prior to signing informed consent * Signed informed consent * Able and willing to fill in questionnaires
Exclusion criteria
* Patients performing HD at home or both home and centre
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of CKD-aP in HD patients | A 7-month study timeline | Percentage (%) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The prevalence of CKD-aP by severity | A 7-month study timeline | none, mild, moderate, and severe |
Countries
Germany, Italy, Portugal, Spain, Sweden, Switzerland, United Kingdom
Outcome results
None listed